Status:
COMPLETED
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Lung Neoplasms
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Medically inoperable lung cancer or metastatic lung tumours will be treated with fractionated stereotactic radiation using a schedule of 1) 12 Gy x 4 treatments or 2) 6 Gy x 10 treatments.
Detailed Description
You will be positioned in a special body mould while you are lying in the treatment position. This ensures that you are treated in the exact position each time. A soft plastic sheet may be placed over...
Eligibility Criteria
Inclusion
- non-small cell lung cancer less than 6cm; no mediastinal or distant metastases
- Open to Alberta,Canada Residents
Exclusion
- tumour size greater than 6cm; inadequate pulmonary function(ie. FEV1 less than 0.8 L), Karnofsky performance status less than 70, multiple co-morbid conditions
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2014
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00351962
Start Date
September 1 2006
End Date
July 2 2014
Last Update
September 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tom Baker Cancer Center
Calgary, Alberta, Canada, T2N 4N2